<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Sat, 29 Aug 2026 17:02:21 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] MLC1抗体に起因するNMOSD様の炎症性脳疾患があるらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110540&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110540&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 17:02:15 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110540&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脂肪酸輸送体CD36阻害で非小細胞肺癌（NSCLC）の膜軟髄膜転移を防ぎうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110539&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110539&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 16:15:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110539&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 原発性アルドステロン症では睡眠中に副腎ステロイド過剰分泌が繰り返される</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110538&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110538&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 16:08:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110538&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] LTBP4欠乏がMRC1+/CD44+マクロファージを生んで大腸癌を進展させる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110537&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110537&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 16:05:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110537&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 単球のインターフェロン反応が高い人にmRNAワクチンの副作用が生じ易い</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110536&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110536&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 15:56:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110536&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 尿路感染症妊婦の早産をIL-10で防ぎうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110535&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110535&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 29 Aug 2026 15:14:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110535&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] バッテン病の類いのCLN3病の網膜変性を酸性セラミダーゼ補充で抑制しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110534&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110534&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 16:42:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110534&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Scarb1遺伝子からのSR-BI発現回復でイノシンが後ろ盾の脂肪分解が復活しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110533&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110533&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 15:30:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110533&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Osivax社がGC社の手持ちと組み合わせたインフルエンザワクチンを開発する</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110532&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110532&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 11:28:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110532&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] エジプトのMinapharm社のブンディブギョワクチンにCEPIが最大1650万ドル提供</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110531&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110531&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 09:39:37 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110531&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Lillyの肥満薬Zepbound使用と医療費が少なくて済むことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110530&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110530&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / その他臨床試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 08:54:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110530&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Gileadの1日1回経口服用HIV薬Bixlenvo（bictegravir/lenacapavir）を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110529&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110529&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 08:30:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110529&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Priovantの経口の皮膚筋炎（DM）薬Lisraya/リスラヤを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110528&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110528&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 28 Aug 2026 08:11:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110528&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Amgen/AstraZenecaの抗TSLP抗体Tezspireの好酸球性食道炎Ph3試験成功</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110527&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110527&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 16:20:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110527&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] GSKの帯状疱疹ワクチンShingrixと心血管疾患生じ難くなることが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110526&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110526&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 13:14:35 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110526&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Akeso/Summitのivonescimab込み胆道癌初治療が中国でのPh3試験で生存改善達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110525&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110525&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 11:25:15 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110525&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 韓国のSK社がBiohaven社のPh2/3試験段階のてんかん薬opakalimを手に入れる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110524&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110524&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 10:00:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110524&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 【増補版】メトホルミン使用と認知症リスク低下が無作為化試験長期追跡で関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110523&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110523&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 09:39:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110523&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Spyreの抗TL1A抗体SPY072のPh2試験での関節リウマチ治療効果が期待外れ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110522&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110522&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 09:34:35 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110522&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 膵癌を治療するRevolutionの活性化KRAS阻害薬Rasonque/ラソンクを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110521&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110521&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 08:51:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110521&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 心筋梗塞後に作られる冠動脈が動脈ではなく毛細血管を端緒とすることが判明</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110520&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110520&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 08:29:09 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110520&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] パン酵母を使ってインフルエンザワクチンを作る技術を開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110519&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110519&amp;ref=rss</guid>
		<category>技術 / 製剤技術 / 全般</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 07:11:49 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110519&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Jazz社のHER2標的薬Ziiheraの胃癌治療2通りを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110518&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110518&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 27 Aug 2026 06:53:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110518&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 温式自己免疫性溶血性貧血へのJ&amp;JのImaavy/アイマービー使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110517&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110517&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 26 Aug 2026 16:35:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110517&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Bausch + Lombのドライアイ薬2つ組み合わせがPh2試験失敗でもPh3試験に進む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110516&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110516&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 26 Aug 2026 14:06:06 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110516&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] コーヒーをよく飲むことと血中の分枝鎖アミノ酸（BCAA）が少ないことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110515&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110515&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 16:30:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110515&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳出血でほぼ盲目の女性の網膜への自家ミトコンドリア移植で視力回復せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110514&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110514&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 14:45:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110514&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] メトホルミン使用と認知症になり難いことが関連</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110513&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110513&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 14:00:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110513&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ムコ多糖症IIIB型を治療する酵素補充薬をSpruce社が今年4Qに米国承認申請する</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110512&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110512&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 13:30:37 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110512&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ph1試験中のHanmi社の肥満薬HM17321のPh2試験からの開発をRocheが引き継ぐ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110511&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110511&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 12:50:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110511&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Regenxbio社のMPS II遺伝子治療RGX-121の臨床試験を米国FDAが再び差し止め</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110510&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110510&amp;ref=rss</guid>
		<category>ビジネス / トラブル / 安全性</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 11:50:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110510&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] CD4細胞傷害性Tリンパ球が高齢になるほど豊富になる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110505&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110505&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 10:10:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110505&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 長く起きていると活性化して眠りにつくことを促すマウスの脳幹神経を発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110504&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110504&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 08:53:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110504&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 武田薬品のナルコレプシー薬Orzeyful/オーゼイフルを日本も承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110509&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110509&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 08:15:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110509&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GSKのB型肝炎薬Hibsago/ヒブサーゴを日本が承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110508&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110508&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 08:10:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110508&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Capricor社の筋ジストロフィー薬deramiocel承認申請補足をFDAが果たして受理</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110507&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110507&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 25 Aug 2026 06:46:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110507&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 室内光には稀で日光には多い藍色光が近視を防ぐらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110506&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110506&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 24 Aug 2026 10:47:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110506&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 頭蓋の骨髄の中にあるリンパ節様の区画が脳の病気を防ぐ役割を担うらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110503&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110503&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 23 Aug 2026 16:45:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110503&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 置かれている状況に即するように脳活動を再編するシロシビンの働きが示された</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110502&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110502&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 23 Aug 2026 14:30:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110502&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ファージが細菌の防御を破るこれまで知られていなかった手段を発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110501&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110501&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 23 Aug 2026 11:49:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110501&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Tecentriq+Avastinが効いた局所進行肝癌の切除が中国での無作為化試験で有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110500&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110500&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 23 Aug 2026 08:22:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110500&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Nektar社のTreg底上げ薬rezpegがアトピー性皮膚炎に効いたPh2b試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110499&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110499&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 17:02:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110499&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Stryker社のロボット（Mako）支援の膝関節置換術の取り柄示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110498&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110498&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 16:36:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110498&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Xspray社の白血病薬Dasynocが再び米国FDA承認を逃す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110497&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110497&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 完全回答（Complete Response Letter）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 15:51:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110497&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Boehringer Ingelheimが経口薬BI 3031185のPh1試験を安全性事態を受けて中断</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110496&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110496&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験 || 開発 / 臨床試験 / 中断</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 15:24:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110496&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GSKの抗TSLP抗体felcorekibart/フェルコレキバートのCOPD/喘息Ph3試験始まる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110495&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110495&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 14:02:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110495&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 慢性腎疾患患者の出血事態を尿素輸送体B阻害薬で予防/治療しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110494&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110494&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 13:12:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110494&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 誰にでも使えるCD33標的CAR-TのPh1試験で白血病解消みられず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110493&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110493&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 12:38:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110493&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 免疫絡み疾患の妊婦が被りうる難儀の生じ易さを血中の剥き出しDNA断片で予想</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110492&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110492&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 10:03:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110492&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] タウ遺伝子のエクソン10をはじくようにするスプライシング調節で神経毒性抑制</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110491&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110491&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 22 Aug 2026 07:15:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110491&amp;ref=rss</comments>
	</item>
</channel>
</rss>
